Royal Bank of Canada’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Buy |
144,064
+144,016
| +300,033% | +$1.63M | ﹤0.01% | 3178 |
|
|
2025
Q1 | $0 | Sell |
48
-689
| -93% | – | ﹤0.01% | 6665 |
|
|
2024
Q4 | $8K | Sell |
737
-3,566
| -83% | -$38.7K | ﹤0.01% | 5922 |
|
|
2024
Q3 | $53K | Buy |
4,303
+958
| +29% | +$11.8K | ﹤0.01% | 5207 |
|
|
2024
Q2 | $45K | Buy |
3,345
+2,252
| +206% | +$30.3K | ﹤0.01% | 5319 |
|
|
2024
Q1 | $14K | Sell |
1,093
-6,451
| -86% | -$82.6K | ﹤0.01% | 5631 |
|
|
2023
Q4 | $40K | Buy |
7,544
+2,912
| +63% | +$15.4K | ﹤0.01% | 5553 |
|
|
2023
Q3 | $18K | Buy |
4,632
+1,673
| +57% | +$6.5K | ﹤0.01% | 5723 |
|
|
2023
Q2 | $32K | Buy |
2,959
+1,617
| +120% | +$17.5K | ﹤0.01% | 5527 |
|
|
2023
Q1 | $11K | Sell |
1,342
-3,679
| -73% | -$30.2K | ﹤0.01% | 5893 |
|
|
2022
Q4 | $46K | Buy |
5,021
+4,667
| +1,318% | +$42.8K | ﹤0.01% | 5471 |
|
|
2022
Q3 | $5K | Buy |
354
+147
| +71% | +$2.08K | ﹤0.01% | 6256 |
|
|
2022
Q2 | $3K | Sell |
207
-1,046
| -83% | -$15.2K | ﹤0.01% | 6391 |
|
|
2022
Q1 | $27K | Sell |
1,253
-2,795
| -69% | -$60.2K | ﹤0.01% | 5961 |
|
|
2021
Q4 | $97K | Buy |
4,048
+2,450
| +153% | +$58.7K | ﹤0.01% | 5441 |
|
|
2021
Q3 | $41K | Buy |
1,598
+291
| +22% | +$7.47K | ﹤0.01% | 5760 |
|
|
2021
Q2 | $44K | Buy |
1,307
+3
| +0.2% | +$101 | ﹤0.01% | 5629 |
|
|
2021
Q1 | $51K | Buy |
1,304
+1,227
| +1,594% | +$48K | ﹤0.01% | 5376 |
|
|
2020
Q4 | $5K | Buy |
+77
| New | +$5K | ﹤0.01% | 6099 |
|
|
2020
Q3 | – | Sell |
-41
| Closed | -$1K | – | 6343 |
|
|
2020
Q2 | $1K | Sell |
41
-48
| -54% | -$1.17K | ﹤0.01% | 6002 |
|
|
2020
Q1 | $2K | Sell |
89
-759
| -90% | -$17.1K | ﹤0.01% | 5825 |
|
|
2019
Q4 | $24K | Buy |
848
+826
| +3,755% | +$23.4K | ﹤0.01% | 5185 |
|
|
2019
Q3 | $0 | Buy |
+22
| New | – | ﹤0.01% | 6160 |
|